PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 1 day 21 hours 21 minutes
The Holistic Care of Patients with T2DM: Going Beyond HbA1c
The Holistic Care of Patients with T2DM: Going Beyond HbA1c
Clinical Conundrums in Type 2 Diabetes: Managing Challenging Cases in Primary Care
Clinical Conundrums in Type 2 Diabetes: Managing Challenging Cases in Primary Care
Optimising Use of Traditional Oral Glucose-Lowering Therapies in Type 2 Diabetes: Important for Patients and Society!
Optimising Use of Traditional Oral Glucose-Lowering Therapies in Type 2 Diabetes: Important for Patients and Society!
Treatment Gaps in T2DM and Obesity: Personalising Care for Better Outcomes
Treatment Gaps in T2DM and Obesity: Personalising Care for Better Outcomes
Personalising Care Across the Disease Continuum: From Prediabetes Through Type 2 Diabetes
Personalising Care Across the Disease Continuum: From Prediabetes Through Type 2 Diabetes
Evaluating the Evidence for SGLT2 Inhibition in CKD: Highlights From the 2021 Virtual ERA-EDTA Congress
Evaluating the Evidence for SGLT2 Inhibition in CKD: Highlights From the 2021 Virtual ERA-EDTA Congress
Evaluating the Evidence for Managing CKD: Highlights From World Congress of Nephrology 2021
Evaluating the Evidence for Managing CKD: Highlights From World Congress of Nephrology 2021
Step-by-Step: Setting a Course for Long-Term Control of Type 2 Diabetes With GLP-1 RAs
Step-by-Step: Setting a Course for Long-Term Control of Type 2 Diabetes With GLP-1 RAs
Why Combination Therapies and Why Now? The Rationale and Role of GLP-1 RAs and Insulin
Why Combination Therapies and Why Now? The Rationale and Role of GLP-1 RAs and Insulin
"Setting New Goals for Slowing Progression in Chronic Kidney Disease: What Is Possible With GLP-1 RAs?"
"Setting New Goals for Slowing Progression in Chronic Kidney Disease: What Is Possible With GLP-1 RAs?"